Fig. 3From: Pharmaceutical efficacy of harmalol in inhibiting hepatocellular carcinomaPhotographic images of gross liver in different groups of experimental mice. a The liver of control mice. b After the 21st week of DEN+ CCl4-injected mice (group V). c Harmalol post-treated miceBack to article page